Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts

Journal of Pathology

Volumn 199, Issue 4, 2003, Pages 453-461

  Soldini, Davide ^a   Gugger, Matthias ^a   Burckhardt, Elisabeth ^a   Kappeler, Andreas ^a   Laissue, Jean A ^a   Mazzucchelli, Luca ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adenocarcinoma; FISH; Genomic; Intraductal papillary mucinous tumour; Mucinous hyperplasia; Numerical chromosomal aberration; Pancreas; Pancreatic intraepithelial neoplasia; Pancreatitis

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CELL CLONE; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 6; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; EPITHELIUM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; MALE; MALIGNANT TRANSFORMATION; MONOSOMY; MORPHOLOGY; NUMERICAL CHROMOSOME ABERRATION; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS INJURY; PANCREAS RESECTION; PANCREAS TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, PANCREATIC DUCTAL; CHROMOSOME ABERRATIONS; CYSTADENOMA, MUCINOUS; DISEASE PROGRESSION; FEMALE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037385581     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1301     Document Type: Article

References (41)

1. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut 1996; 39: 457-464.
2. Loftus EV Jr, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology 1996; 110: 1909-1918.
3. Paal E, Thompson LD, Przygodzki RM, Bratthauer GL, Heffess CS. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999; 12: 518-528.
4. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol 1997; 28: 1010-1017.
5. Tada M, Omata M, Ohto M. Ras gene mutations in intraductal papillary neoplasms of the pancreas: analysis in five cases. Cancer 1991; 67: 634-637.
6. Z'graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997; 226: 491-498.
7. Sato N, Rosty C, Jansen M, et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001; 159: 2017-2022.
8. Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997; 151: 1447-1454.
9. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 357-367.
10. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 2000; 157: 755-761.
11. Inoue H, Furukawa T, Sunamura M, Takeda K, Matsuno S, Horii A. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. Genes Chromosomes Cancer 2001; 31: 295-299.
12. Wilentz RE, Argani P, Hruban RH. Loss of heterozygosity or intragenic mutation, which comes first? Am J Pathol 2001; 158: 1561-1563.
13. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological typing of tumors of the exocrine pancreas. In Who International Histological Classification of Tumors. Springer: Berlin.
14. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25: 579-586.
15. Mazzucchelli L, Burckhardt E, Hirsiger H, Kappeler A, Laissue JA. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland. Hum Pathol 2000; 31: 854-859.
16. Hopman AH, van Hooren E, van de Kaa CA, Vooijs PG, Ramaekers FC. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 1991; 4: 503-513.
17. Gugger M, Burckhardt E, Kappeler A, Hirsiger H, Laissue JA, Mazzucchelli L. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol 2002; 196: 408-415.
18. Luttges J, Galehdari H, Brocker V, et al. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 2001; 158: 1677-1683.
19. Kawahira H, Kobayashi S, Kaneko K, Asano T, Ochiai T. p53 protein expression in intraductal papillary mucinous tumors (Ipmt) of the pancreas as an indicator of tumor malignancy. Hepatogastroenterology 2000; 47: 973-977.
20. Islam HK, Fujioka Y, Tomidokoro T, et al. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas: diagnostic and biologic significance. Hepatogastroenterology 1999; 46: 2599-2605.
21. Flejou JF, Boulange B, Bernades P, Belghiti J, Henin D. p53 protein expression and DNA ploidy in cystic tumors of the pancreas. Pancreas 1996; 13: 247-252.
22. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 1994; 9: 93-100.
23. Griffin CA, Hruban RH, Morsberger LA, et al. Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 1995; 55: 2394-2399.
24. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 2000; 156: 2123-2133.
25. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Pathol 2000; 156: 1821-1825.
26. Nagai E, Ueki T, Chijiiwa K, Tanaka M, Tsuneyoshi M. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called 'mucinous ductal ectasia'. Histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 1995; 19: 576-589.
27. Ratcliffe N, Terhune PG, Longnecker DS. Small intraductal papillary-mucinous adenomas of the pancreas. Arch Pathol Lab Med 1996; 120: 1111-1115.
28. Bastid C, Bernard JP, Sarles H, Payan MJ, Sahel J. Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis. Pancreas 1991; 6: 15-22.
29. Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000; 95: 441-445.
30. Sho M, Nakajima Y, Kanehiro H, et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg 1998; 22: 874-878.
31. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery 2000; 127: 536-544.
32. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437.
33. Knuutila S, Aalto Y, Autio K, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-694.
34. Sheng ZM, Marchetti A, Buttitta F, et al. Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer 1996; 73: 144-147.
35. Theile M, Seitz S, Arnold W, et al. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 1996; 13: 677-685.
36. Offit K, Parsa NZ, Gaidano, G, et al. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82: 2157-2162.
37. Orphanos V, McGown G, Hey Y, et al. Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer 1995; 71: 666-669.
38. Orphanos V, McGown G, Hey Y, Boyle JM, Santibanez-Koref M, Proximal. 6q, a region showing allele loss in primary breast cancer. Br J Cancer 1995; 71: 290-293.
39. Bell DW, Jhanwar SC, Testa JR. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 1997; 57: 4057-4062.
40. Barghorn A, Speel EJ, Farspour B, et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol 2001; 158: 1903-1911.
41. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001; 116: 79-86.